Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
Stefanie Quach, Adrien Holzgreve, Louisa von Baumgarten, Maximilian Niyazi, Marcus Unterrainer, Niklas Thon, Sophia Stöcklein, Peter Bartenstein, Jörg‐Christian Tonn, Nathalie L. Albert
Abstract
Quach S, Holzgreve A, von Baumgarten L, et al. Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation? <em>European Journal of Nuclear Medicine and Molecular Imaging</em>. 2022;49(12):4282-4283.
Topics & Concepts
GliomaImmune systemMedicineWild typeCancer researchNuclear medicineOncologyChemistryImmunologyGeneMutantBiochemistryGlioma Diagnosis and TreatmentNanoplatforms for cancer theranosticsBrain Metastases and Treatment